Survivors of childhood central nervous system cancer show affected self-identity
the ONA take:
According to a new study published in the journal Neuro-Oncology, researchers from the Korlinska Institutet in Sweden have found that patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception and self-identify later in adulthood.
For the study, researchers followed 700 adult survivors of childhood CNS cancer who were diagnosed between 1992 and 2001. Researchers compared these patients to a control group from the general population. They studied how the cancer, the treatment, and the aftermath affected the patient's health, function, and psychological identity. Psychological identity includes their self-perception and self-esteem, which researchers assessed using a standardized self-report questionnaire.
Results showed that all components of having CNS cancer affected patients' psychological identity later in adulthood. Researchers found survivors more often had a negative self-perception compared with the control group.
For example, in the context of work and friends, 22% and 30% of survivors had a negative self-perception, respectively, while 8% and 17% of the control group had a negative self-perception, respectively.
Results of self-perception were similar across both groups in the context of family. Findings suggest that more preventative measures are necessary to aid in long-term personality development.
Patients treated for CNS cancer during childhood can display altered self-perception later in adulthood.
The study followed 700 adult survivors diagnosed 1992-2001 with a childhood CNS tumour. The study group covered all adult brain tumour survivors in Sweden at the time of start of study. Patients were compared with a control group selected from the general population.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|